GLIMIHEAL M1 is a combination tablet containing Glimepiride 1 mg and Metformin Hydrochloride sustained‑release 500 mg, used to manage type 2 diabetes when diet and exercise alone are insufficient .
Glimepiride stimulates insulin production from the pancreas, while Metformin SR reduces glucose production in the liver and improves insulin sensitivity—together offering dual-action blood sugar control .
Common side effects include hypoglycemia (low blood sugar), gastrointestinal symptoms like nausea, diarrhea, or abdominal discomfort, headache, and, rarely, lactic acidosis or vitamin B₁₂ deficiency with long‑term use—doses
